Reports Q4 revenue $42.98M, consensus $42.14M. “The fourth quarter of fiscal 2024 was a high point for the company,” stated Nick Green, president and CEO of Avid Bioservices. “We generated the highest quarterly revenues in Avid’s history, meeting our current revenue expectations for the year. During the period we signed multiple new project agreements, and we continue to see positive signs for business development in the year ahead. Given our strong backlog and robust proposal pipeline we are looking ahead to a promising 2025, and are providing 2025 full fiscal year revenue guidance of between $160 million and $168 million, representing 17% growth year-over-year at the midpoint.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDMO:
- Options Volatility and Implied Earnings Moves Today, July 02, 2024
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
- Avid Bioservices, Inc. (CDMO) Q4 Earnings Cheat Sheet
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance
- Avid Bioservices to Participate at Upcoming Investor Conferences
Questions or Comments about the article? Write to editor@tipranks.com